Innovation for Sight
There will be a major change on Glaucoma Treatment soon..
Innovation for Sight
There will be a major change on Glaucoma Treatment soon..
GlaucoT
NeuroProtective Glaucoma Treatment Device
World first and patented neuroprotective glaucoma treatment device
Pressure control over Optical Nerve
By applied Vacuum around the eye globe, Mechanical damages on optical nerve could be reduce
Increased Ocular Blood Flow
Ocular blood flow could be increased by a flicker light
Benefits
Wearable tech device for "at home" treatment
Patient will use GlaucoT at home, with pleasure by their prefered time and will get rid of from glaucoma, You could get pleasure of drinking coffee when you are wearing GlaucoT and treat your glaucoma
NeuroProtection without Drug
We will protect the brain and visual cortex from damaging effect of glaucoma by 40Hz flicker light not with drugs. 40 Hz light is at actually the rthyme of our body and maximum frequency which human eye can see.
Non Invasive
This is simple medical consumer electronic device. You don't need to have any surgery or operation to use it so its a non-invasive treatment.
Glaucot is Number 1
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
GlaucoT won first place out of 471 projects participating in TET R&D Project Brokerage Event organized by TET - Electrical and Electronics Exporters Association
https://www.tetprojepazari.org/tr/Default.aspx
Göz Tansiyonu (glokom) Tedavisi için geliştirdiğimiz GlaucoT projemiz TET Tarafından düzenlenen 9. Proje Pazarın etkinliğinde 471 proje arasından birinci seçildi. Tüm ekibimize ve bu projede bize destek olan TTGV HIT programına teşekkür ediyoruz. #glokom #glaucoma #ttgv #immib
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
GlaucoT, World First, noninvasive neuroprotective Glacuoma treatment device on the way, pleasure to get support from TTGV HIT
GlaucoT, dünyanın ilk noninvaziv nöroprotektif Glokom (Göz Tansiyonu) tedavi cihazı yolda, TTGV HIT'den destek almak gurur verici
#TeknolojiÜretenTürkiye #TTGV #glaucoma #glokom #göztansiyonu #innovation #HitProgramı #GlaucoT
We will be at CES 2020
We will be at CES 2020
We will be at CES 2020
We will be at Sands, Hall G - 51322, you could see our working prototype device and we will be more than happy to meet investors for such important project
Acıbadem Incubator
We will be at CES 2020
We will be at CES 2020
Our Co-founder Dr. Abdülkadir Oduncu has attended immense training at Acıbadem Incubation center for GlaucoT project commercialization